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Introduction
During acute respiratory infections in cystic fibrosis,
resting energy expenditure is increased due to fever,
inflammatory responses and nutritional requirements. This
results in reduced pulmonary function and indirect
increases in the work of breathing (Gozal et al 1992,
Steinkamp et al 1993). Resting energy expenditure has
been reported to be reduced significantly by the completion
of a hospital admission for intensive medical management
of an acute respiratory exacerbation for subjects with cystic
fibrosis (Naon et al 1993, Steinkamp et al 1993).
Despite the substantial research into the physiotherapy
management of cystic fibrosis, there are insufficient
studies which investigate the efficacy of physiotherapy or
compare different physiotherapy regimens during
admission to hospital for management of acute pulmonary
exacerbation. Of these studies, few have been conducted
during the early stages of an admission (Oberwalder et al
1991, Pryor et al 1990, Regelmann et al 1990). Patients
requiring hospitalisation due to worsening pulmonary
function are likely to be most compromised clinically and
metabolically during the initial days of an admission. This
study measured the energy expended during, and
pulmonary function changes following, therapist-assisted
treatment compared with independent physiotherapy
treatment of subjects with cystic fibrosis during acute
respiratory exacerbations of their disease.
Methods
Subjects were current patients of the specialist Cystic
Fibrosis Clinic of the Women’s and Children’s Hospital,
Adelaide, admitted to hospital for management of an acute
exacerbation of their respiratory disease. Ethical approval
for this study was granted by the relevant committees of the
Women’s and Children’s Hospital, and the University of
South Australia. All subjects with cystic fibrosis admitted
to hospital for management of an an acute respiratory
infection were invited to participate in this study. Subjects
were required to be 12 years of age or older and able to fast
prior to testing (preferably overnight). The criteria for
determining an acute respiratory infection was based on the
definition provided by Gold et al (1987), that is, subjects
were required to fulfil at least three of the following
criteria: 1) acute respiratory exacerbation characterised by
increased cough, volume and purulence of sputum, fatigue,
tachypnoea and dyspnea; 2) decreased exercise tolerance;
3) anorexia and weight loss, alone or in combination; and
4) sufficiently severe condition, judged by a physician of
the Cystic Fibrosis Clinic, to require hospitalisation.
Plan and design The research design was of the within-
subject, repeated measures 2 x 2 (AB/BA) cross-over style
with a 24 hour washout period. Subjects acted as their own
control and undertook both treatments. The subjects were
randomly assigned to undergo either the therapist-assisted
treatment followed 24 hours later by the independent
treatment (AB protocol), or the independent treatment
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followed 24 hours later by the therapist-assisted treatment
(BA protocol). Patients were admitted on Day Zero and
underwent required medical management procedures.
Thereafter, research testing occurred on Day 1 and Day 2
of the admission as well as the morning of the day of
discharge, Day X. All testing was carried out during the
morning and at the same time each day. If subjects were
unable to complete the trial for any reason, they were
withdrawn from the study. Subjects continued with their
preferred physiotherapy programs and prescribed
medications throughout the study. Sympathomimetic
agents can increase resting energy expenditure (Vaisman et
al 1987) however these drugs could not be withheld from
subjects requiring these agents as part of their medical
management. Their usage continued but the timing and
dosage were kept the same between days of the study.
Treatments The most common physiotherapy regimen
throughout Australia for the management of patients with
cystic fibrosis admitted to hospital is the ACBT
incorporating manual techniques and gravity-assisted
positioning (Bartlett et al 1993). The ACBT was performed
according to guidelines developed by Partridge et al (1989)
and Pryor (1991). 
During pilot work for this project, the duration of standard
physiotherapy treatments and frequency of ACBT cycles
within daily treatment were recorded and monitored. On
average, the duration of each treatment session was
approximately 20 minutes, each standardised ACBT cycle
was around two minutes, with variations due to
spontaneous coughing and recovery time using breathing
control. During the study the total number of ACBT cycles
performed during the treatment phase was individualised
and not set, however the standardised ACBT study regimen
was controlled. 
The standardised ACBT study regimen was used in both
the therapist-assisted and independent regimens. The
standardised ACBT consisted of breathing control, four
thoracic expansion exercises, breathing control, three
thoracic expansion exercises, breathing control, two forced
expirations (huffs and breathing control) (Pryor 1991). 
Therapist-assisted ACBT: the physiotherapist provided
manual (tactile) facilitation during the thoracic expansion
exercises and huffing. Percussion was applied at
approximately 133 bpm during the first set of thoracic
expansion exercises and vibration during the second set of
thoracic expansion exercises
Independent ACBT: the patient performed the ACBT under
the supervision and with the verbal guidance of the
physiotherapist. 
Treatment position: The treatment was conducted in the
same gravity-assisted position on both treatment days,
determined by auscultation during the baseline measures
on the first day of testing. Only one gravity-assisted
position was maintained throughout the 20min treatment
period as Webber (1988) recommends that a minimum of
10 minutes in one position is required for gravity to
influence secretion movement and a position change
midway throughout treatment would confound the energy
expenditure measurements. All subjects were familiar with
both treatment regimens and the same physiotherapist was
in attendance for all subjects.
Equipment Energy expenditure was measured by indirect
calorimetry. A low deadspace exercise mask (Hans
Rudolph Exercise Series 7910) maintained a leak-free
contact with the subject’s face. This mask has two
inspiratory ports and one expiratory port, each complete
with one-way valves. Minute ventilation (L/min) was
measured with a pneumotachometer (Fleisch Size 3,
unheated) inserted into one inspiratory port, and was
connected to a Validyne MP-45 differential pressure
transducer which relayed signals to a Hewlett Packard
amplifier (Model 77028). The inspiratory flow signal was
integrated digitally and converted to expiratory volume via
the standard nitrogen correction (Ruppel 1991). The
second inspiratory port was fitted with a gas-tight secretion
removal system consisting of a suction cannula and
specimen trap, a control valve attached to a water
displacement system and wall suction (negative 150
mmHg; Parsons and Williams 1996). While sputum was
expectorated during treatment, the volume was not
measured, nor considered during analysis, as there is no
convincing evidence that volume of sputum equates with
pulmonary function, and it is likely to underestimate
airways secretion clearance (Williams et al 2000).
The expiratory port was connected via smooth bore tubing
to a 4L mixing box. Concentrations of oxygen (per cent)
and carbon dioxide (per cent) were determined by Ametek
S-3A/1 (oxygen) and Bio Precision B1050-0001 (carbon
dioxide) analysers. Analogue output signals were converted
via an A-D board (Metrabyte DAS-8) to digital signals at
30Hz for real-time display, analysis and storage. Values for
minute ventilation, mean expired oxygen and carbon
dioxide were continuously monitored and stored using
computer software (Labtech Notebook). Mean mixed-
expired gas values were corrected for both ambient
conditions (STPD) and time delays due to gas transport
through the collection system. Oxygen consumption (VO
2
),
carbon dioxide production (VCO
2
) and respiratory
exchange ratio (RER) were calculated via standard
equations and expressed as mean values per minute
corrected for body weight (ie VO
2
ml/kg/min, VCO
2
ml/kg/min, VCO
2
/VO
2
, Ruppel 1991). The ventilatory
equivalent for oxygen (Ve/VO
2
) was calculated during the
analysis phase (Ruppel 1991). Resting oxygen saturation
(% SpO
2
) and heart rate (bpm) were recorded throughout
the testing procedure using a Nelcor 200E Pulse Oximeter
(taped finger interface).
The indirect calorimetry system was calibrated against a
rotameter (CEC-Elliot) for flow and a 120L Tissot
spirometer for volume. Alpha-standard gas mixtures of
oxygen, carbon dioxide and nitrogen were used to calibrate
the gas analysers. Measures for flow and volume were
accurate to 3%, which is within the widely accepted
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American Thoracic Society standards (1991). Gas analysis
for carbon dioxide and oxygen was accurate to 0.02%.
Reliability of resting indirect calorimetry measures for the
test procedure was confirmed in a previous study, with VO
2
(r = 0.72), VCO
2 
(r = 0.72), and Ve (r = 0.89) producing
acceptable correlations between days of testing (Williams
et al 1994). Inspiratory flow, volume and gas sensors were
calibrated prior to each subject’s test.
Baseline measurements: The subject’s age and gender were
recorded, and height and weight were measured with a wall
stadiometer (Holtain Limited) and calibrated scales,
respectively. Dynamic pulmonary function was assessed by
flow/volume curves and whole body plethysmography
using a Jaegar MasterLab system. Predicted values were
derived from the equations of Zapletel et al (1969) and
Crapo et al (1981) for subjects between four and 18 years
of age. Pulmonary function studies were performed by the
principal investigator with the subjects standing for
flow/volume manoeuvres and seated within the body box
for plethysmography.
After the calorimetry and oximetry equipment was
connected, the subject rested quietly in the sitting position
(sitting with trunk at 45 degrees above horizontal on an
Evans postural drainage bed) for 15 minutes while
calibration procedures for the gas-analysis equipment were
carried out. This time allowed for stabilisation of metabolic
rate and for saturation of the gas mixing box with expired
moist air; baseline energy expenditure was then measured
for 20 minutes. The subject was then positioned for
treatment and 20 minutes of either the assisted ACBT or
independent ACBT commenced. Cough and huff frequency
were recorded throughout the test procedure. Coughing
was defined as a spontaneous, uncontrolled manouvre,
whereas huffing refers to a specific component of the
treatment phase as instructed by the physiotherapist. The
computer screen and equipment displays were not visible to
the physiotherapist or subjects. No measurements were
made during repositioning procedures.
On completion of the 20min treatment period, the subject
rested in the sitting position for a further 40 minutes;
measurements were continued throughout this time and
were recorded as two 20min periods, designated Recovery
1 and Recovery 2. Once the indirect calorimetry and
oximetry equipment were removed, pulmonary function
tests were again performed. The same procedure, but with
the alternate treatment, was carried out 24 hours later.
Throughout the measurement periods (baseline, treatment,
recovery), inspired and expired gas volumes, expired
concentrations of oxygen and carbon dioxide, oxygen
saturation and heart rate were continuously recorded and
the frequency of spontaneous coughing was recorded.
On the day of discharge from hospital, pulmonary function
tests were repeated (flow/volume loops and body
plethysmography). Resting energy expenditure and
oximetry were monitored for 20 minutes following 15
minutes of stabilising time. Weight was measured to
establish weight loss or gain during admission and resting
energy expenditure on discharge was calculated using the
weight at discharge.
Analysis Day-to-day variability in oxygen consumption
has not previously been reported for acutely unwell patients
with cystic fibrosis. Therefore a preliminary test based on
the resting oxygen consumption values for both days of
testing for the first 10 subjects enrolled in this study was
used to estimate daily variability in the primary outcome
measure, oxygen consumption. Results of this test gave a
standard deviation of 0.53 ml/kg/min where 10% of the
mean is approximately 0.5 ml/kg/min. A sample size of 12
was required to ensure sufficient discriminating power
(Type I error probability of 0.05, Type II error probability
of 0.20, statistical power of 80%, between treatment
regimens for oxygen consumption. Statistical analysis was
calculated using the Minitab software package (Minitab
Inc, Version 7.2). Results are presented as means and
standard deviations unless otherwise indicated.
A two-way ANOVA (group and treatment) was used to
determine whether physiotherapy resulted in differences
between baseline and treatment. This was followed by
cross-over two-sample t-tests to determine differences
between regimens for responses to treatment for indirect
calorimetry and pulmonary function parameters with 
p < 0.05 regarded as significant (Jones and Kenward 1989).
The influence of carry-over, period, and interaction effects
were also analysed. Carry-over effects refer to the effects of
the initial treatment resulting in changes to the baseline of
the second treatment. The effect of the test day, rather than
the specific treatment, is the period effect. Significant
relationships between treatments and days are termed
interaction effects.
Results
Data were collected over a 14 month period (May 1995 to
July 1996). Nineteen subjects consented to undertake the
study. Four subjects failed to complete the procedure: one
12-year-old female was unable to cough effectively while
wearing the Hans Rudolph Exercise mask during treatment
stage; two stopped the test during the baseline data
collection stage due to nausea (12-year-old male and 16-
year-old male); and one subject failed to attend on the
second day of testing (12-year-old male). Fifteen subjects,
six female and nine male, completed the experimental
procedure (Assisted/Independent protocol = 7;
Independent/Assisted protocol = 8). Descriptive details for
this group are contained in Table 1. Twelve subjects had
mild pulmonary impairment (FEV
1
> 60% predicted;
American Thoracic Society 1991) and three had moderate
pulmonary impairment (FEV
1
40-60% predicted). No
subjects were regarded as having severe pulmonary
impairment (FEV
1
< 40% predicted). There was no
statistical difference in pulmonary function between the
two treatment groups (AB or BA) prior to the initial
treatment on Day 1 as calculated by two-sample t-tests 
(p values ranged from 0.15 - 0.97).
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Indirect calorimetry parameters No significant
differences were observed when mean resting values for
indirect calorimetry parameters were compared between
the AB and the BA group for Day 1. Mean and standard
deviation (SD) values for all parameters are presented in
Table 2. Good to excellent correlations were demonstrated
for all parameters when baseline values were compared
between the two days of testing (r ranging from 0.67 to
0.93), with the exception of cough frequency (r = 0.40).
The coefficient of variation for resting VO
2
between days
was 11%. When comparing baseline values with values
during physiotherapy treatment, there were significant
increases in VO
2
ml/kg/min (STPD) (p = 0.008; 10.7%),
VCO
2
ml/kg/min (STPD) (p < 0.001; 19.4%) and the RER
(p = 0.005; 7.2%). In addition, there was a small increase
in Ve (p = 0.32; 4.8%) and SpO
2
(p = 0.34; 0.4%) and a
small decrease in Ve/VO
2
(p = 0.21; 5.2%) and heart rate 
(p = 0.83; 0.5%); however these latter changes were not
significant. The frequency of coughing during treatment
was found to be greater than during baseline (p < 0.001).
Using two-sample cross-over t-tests, when the therapist-
assisted ACBT and independent ACBT regimens were
compared during the first two days of the admission, no
significant differences were found for Ve (p = 0.76),
VO
2
ml/kg/min (STPD) (p = 0.32), VCO
2 
ml/kg/min
(STPD) (p = 0.79), RER (p = 0.59), Ve/VO
2
(p = 0.49),
SpO
2
(p = 0.28), heart rate (p = 0.22) or cough/huff
frequency (p = 0.43).
No carry-over or treatment by period interactions were
demonstrated for any parameter. However there were
significant period effects for Ve (p = 0.046), VO
2
ml/kg/min (STPD) (p = 0.02) and VCO
2
ml/kg/min (STPD)
(p = 0.01); that is, the difference between baseline and
treatment was smaller on the second day of treatment.
Table 1. Descriptive details for the sample of 15 acute cystic fibrosis subjects on admission and discharge from hospital.
Parameter Admission Day 1 Discharge
n = 15 n = 15
mean      (SD) mean        (SD)
Age (years) 15.4 (1.4) 
Gender 6 F, 9 M
Weight (kg) 56.65 (8.6) 57.9 (10.5)  
Weight (% predicted ) 88.8 (9.1) 90.4 (9.0)  
Height (cm) 164.15 (10.2)
Length of admission (days) 15.6 (3.6)  
Pulmonary function (% predicted)
FVC 97.3 (17.6) 103.1 (13.2)  
FEV1 88.1 (21.6) 96.0 (15.5)  
FEV1/FVC 93.8 (12.5) 97.2 (9.4)  
PEF 94.6 (27.7) 107.1 (23.3)  
FEF25 97.0 (37.2) 111.2 (34.9)  
FEF50 86.8 (37.5) 103.8 (35.9)  
FEF75 68.9 (32.3) 74.6 (29.3)  
FEF25/75 75.5 (27.9) 85.7 (29.3)  
TLC 102.4 (11.4) 104.6 (11.6)  
ITGV 107.5 (14.2) 110.4 (20.6)  
RV 134.2 (22.7) 124.8 (26.4)  
RV%TLC 138.7 (22.0) 123.4 (22.4)  
Key:
FVC = forced vital capacity, FEV1 = forced expiratory volume in one second, FEV1/FVC = ratio of forced expiratory
volume to forced vital capacity, PEF = peak expiratory flow, FEF25 = forced expiratory flow at 25% of vital capacity, 
FEF50 = forced expiratory flow at 50% of vital capacity, FEF75 = forced expiratory flow at 75% of vital capacity,
FEF25/75 = forced expiratory flow between 25% and 75% of vital capacity, TLC = total lung capacity, ITGV =
intrathoracic gas volume, RV = residual volume, RV%TLC = residual volume as a percentage of total lung capacity
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When baseline values for indirect calorimetry parameters
were compared between the first day of testing and
discharge using two-sample cross-over t-tests, significant
increases were found for VCO
2
(p = 0.02, 10.5%) and RER
(p = 0.002, 11.2%) (Table 2). Although there were
increases in other parameters, these were not statistically
significant.
Pulmonary function Cross-over two-sample t-tests were
calculated for each pulmonary function variable between
pre- and post-treatment measurements on both days of
testing. No significant differences were found for any
pulmonary function variable between the initial two days
of testing. Additionally, no significant improvement or
deterioration in pulmonary function was demonstrated
immediately following physiotherapy treatment for either
treatment regimen.
A significant carry-over effect was demonstrated for the
FEV
1
/FVC ratio (p = 0.047) where the therapist-assisted
ACBT resulted in a 7.9% increase in pre-treatment values
on day two, whereas the independent treatment resulted in
0.5% increase (Table 3 and Figure 2). There were also
carry-over effects for FEV
1
(p = 0.07), FEF
50
(p = 0.08),
FEF
75
(p = 0.08) AND MMEF
25/75
(p = 0.06), but these
failed to reach statistical significance. That is, when the
therapist-assisted ACBT was conducted on Day 1, there
were improvements in baseline values for these parameters
on Day 2.
Pulmonary function values were compared using paired 
t-tests between the pre-treatment Day 1 of testing and the
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Table 2. Mean and standard deviation for indirect calorimetry parameters throughout the experimental procedure for the
acute cystic fibrosis subjects  “Assisted ACBT” is the therapist-assisted ACBT.
Parameter Regimen Baseline Treatment Recovery 1 Recovery 2 Discharge  
Ve Assisted ACBT 8.11 8.53 7.88 7.92 8.27
L/min  (1.58) (1.37)  (1.82) (1.87) (1.31)  
Independent ACBT 8.08 8.45 7.45 7.36
(1.44) (1.77)  (1.41)  (1.08)   
VO2 Assisted ACBT 5.08 5.68 5.23 5.23 5.39
ml/kg/min (0.61)  (0.85) (0.65) (0.56) (0.82)   
Independent ACBT 5.10 5.58 5.12 5.06
(0.64) (0.95) (0.70) (0.61)   
Ve/VO2 Assisted ACBT 1.61 1.51 1.52 1.52 1.48(0.32) (0.21) (0.40) (0.36) (0.50)   
Independent ACBT 1.59 1.52 1.46 1.45
(0.25) (0.22) (0.31) (0.16)   
VCO2 Assisted ACBT 4.97 5.94 4.73 4.91 5.49
ml/kg/min (0.69) (0.65) (0.62) (0.55) (0.81)  
Independent ACBT 4.98 5.94 4.62 4.72
(0.76) (0.88) (0.80) (0.72)   
RER Assisted ACBT 0.95 1.02 0.87 0.91 1.06
(0.07) (0.10) (0.10) (0.10) (0.10)   
Independent ACBT 0.95 1.01 0.89 0.93
(0.07) (0.10) (0.11) (0.07)   
Heart Rate Assisted ACBT 85.83 86.29 84.55 83.65 82.71
bpm (8.90) (8.19) (9.72) (9.30) (10.65)   
Independent ACBT 85.42 83.91 82.16 79.45
(10.7) (10.63) (12.14) (7.99)   
Oxygen  Assisted ACBT 96.07 96.56 96.38 96.97 96.32
Saturation% (1.61) (1.99) (1.53) (1.53) (0.92)   
Independent ACBT 96.13 96.53 95.90 96.45
(1.66) (1.93) (1.55) (1.49)   
Cough Assisted ACBT 1.8 13.53 1.73 1.33 1.26
Frequency (2.07) (9.07) (2.46) (1.63) (2.84)   
Independent ACBT 2.6 13.26 1.40 1.26
(3.06) (5.86) (2.06) (1.70)   
Forced expiratory Assisted ACBT 26.00
manoeuvres (7.70)
(cough+huff) Independent ACBT 26.66
(5.16)
Australian Journal of Physiotherapy 2001  Vol. 47232
Williams et al: Acute respiratory infection in patients with cystic fibrosis with mild pulmonary impairment
day of discharge. Significant changes were observed for
RV (p = 0.049, mean decrease of 7%) and RV%TLC 
(p = 0.02, mean decrease 9.5%) and statistically non-
significant changes were demonstrated for FVC (p = 0.06,
mean increase of 5.9%), FEV
1
, (p = 0.07, mean increase of
9%) and FEF
50
(p = 0.05, mean increase of 19.5%).
Discussion
In this group of patients with cystic fibrosis and
predominantly mild pulmonary impairment, energy
expenditure during chest physiotherapy treatment exceeded
energy requirements at rest. The physiotherapy regimens
consisted of sequential but repetitive cycles of respiratory
muscle work resulting in differences in the breathing
pattern, ventilatory volumes, velocity of airflow and cough
frequency when compared with the resting period. For
these reasons alone, physiotherapy could be expected to
result in increased energy requirements. While position
changes between baseline, treatment and recovery may
have influenced energy expenditure measurements, no data
were recorded during these postural changes and data
collection was recommenced only when the subjects
indicated they were comfortable and relaxed.
Resting VO
2
values for these acutely unwell subjects with
cystic fibrosis (5.08 (0.61) ml/min/kg) are comparable with
previous studies. Cropp and Rosenberg (1981) found that
in a group of 16 clinically stable cystic fibrosis subjects
(age of 19.5 (2.38)), resting oxygen consumption was 4.92
(0.31) ml/min/kg in subjects with cystic fibrosis and 3.16
(0.20) ml/min/kg in normal control subjects. Hirsch et al
(1989) compared a group of nine normal subjects (age
range 13 to 28 years) and 13 cystic fibrosis subjects with
moderate to severe pulmonary impairment (age range 11 to
31 years, FEV
1
47 (22.9), FVC 67 (25.4)) and found an
average resting oxygen consumption of 3.2 ml/min/kg in
normal subjects and 5.3 ml/min/kg in subjects with cystic
fibrosis. 
While the resting values for cystic fibrosis subjects
reported in this current study are higher than normal
control values, it appears that the energy cost of
physiotherapy was modest compared with published
reports of maximal oxygen consumption in cystic fibrosis
subjects. Shah et al (1998) reported the maximal oxygen
consumption of 17 cystic fibrosis subjects (age 25 (10),
FEV
1
62 (21)) as VO
2 
max 24.6 (6.0) ml/min/kg. This
suggests that while physiotherapy requires approximately a
10% increase in energy expenditure, this is neglible
compared with the maximal capacity of oxygen
consumption. 
No significant difference was found between indirect
calorimetry parameters of independent and therapist-
assisted treatment in this group of cystic fibrosis patients.
Furthermore, no significant difference was found in the
frequency of forced expiratory manoeuvres, heart rate or
oxygen saturation between the two forms of treatment.
Physiotherapy treatment of either kind resulted in smaller
differences between baseline to treatment on the second
day of treatment for minute ventilation, VO
2
ml/kg/min
(STPD) and VCO
2
ml/kg/min (STPD). This suggests that
subjects, in general, expended less energy during treatment
on the second day of treatment. The initial physiotherapy
treatment may have had a role in reducing the expenditure
of energy during treatment on the second day, possibly by
facilitating secretion clearance and improving the
distribution of ventilation. However, the subjects were also
receiving intravenous antibiotics, supplemental vitamins,
bronchodilating medication and nutritional support. The
Table 3. Raw data for the carry-over effect demonstrated for FEV1/FVC.
Assisted/Independent Independent/Assisted 
regimen (AB) n = 7  regimen (BA) n = 8    
Day 1 pre Day 2 pre Diff Day 1 pre Day 2 pre Diff
65.7 70.2 4.5 83.6 86.1 2.5   
77.3 99.4 22.1 82.7 86.5 3.8   
93.8 102.0 8.2 103 103 0.0
105.0 107.0 2 88.1 87 -1.1   
105.0 110.0 5 93.4  96.6 3.2   
104.0 113.0 9 104.0 102.0 -2.0
99.6 100.0 0.4 111.0 110.0 -1.0
90.3 88.9 -1.4  
mean 92.9 100.2 7.3 94.5 95.0 0.5  
p = 0.81* p = 0.40**
* Two-sample t-test AB Day 1 pre vs BA Day 1 pre
** Two-sample t-test AB Day 2 pre vs BA Day 2 pre
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consistent reduction in differences between baseline and
treatment values on the second morning of testing suggests
that the overall constitution of the subjects had improved,
resulting in less effort expended during physiotherapy.
Immediately following physiotherapy treatment, there was
no significant change in any pulmonary function variable.
However, with the therapist-assisted form of chest
physiotherapy the FEV
1
/FVC ratio exhibited a significant
positive carry-over effect, while FEV
1
, FEF
50
, FEF
75
,
MMEF
25/75
demonstrated carry-over effects which failed to
reach the required level of significance. Given that at least
23 subjects would have been required for sufficient
statistical power to confidently determine pulmonary
function differences between physiotherapy regimens, the
results of the 15 subjects who were able to be recruited may
well have reached statistical significance with an increased
sample size. The carry-over effects for pulmonary function
parameters were associated with the AB protocol. That is,
when the therapist-assisted ACBT was conducted on Day 1,
there was a significant improvement in baseline values on
Day 2.
One explanation for these improvements in pulmonary
function for the AB regimen is the potentially confounding
effects of cough frequency and any additional
physiotherapy treatments during the washout period. It is
possible that the increased cough frequency during
treatment may have been responsible in part for
augmenting secretion clearance rather than the manual
techniques of percussion and vibration. However, the
frequency of forced expiratory manoeuvres (cough and
huff) between the two regimens was similar and, if forced
expiratory manoeuvres were the predominant reason for
improvements in pulmonary function, these improvements
should have occurred for both regimens rather than just the
therapist-assisted form. 
Subjects were required to continue their normal
physiotherapy management during the intervening time
between test mornings. The use of the cross-over t-tests to
analyse carry-over effects effectively negates confounding
effects of further treatments if only one group shows
significant improvement. That is, for the AB group to show
significant improvements in pulmonary function on Day 2,
only these subjects would have had to perform additional
chest physiotherapy which resulted in improved pulmonary
function, while the BA group would have to either not
perform chest physiotherapy or perform chest
physiotherapy which did not alter or improve pulmonary
function. 
When the medical management and physiotherapy
treatments during the 24 hour washout period were
compared, no differences could be found which might
contribute to the carry-over effect for the AB group.
Fourteen of the 15 subjects had two further physiotherapy
treatments between the first and second day of the study
(one subject had one further physiotherapy treatment; BA
group). Each treatment was of 15-20min duration and
consisted predominantly of positive pressure mask therapy
in the sitting position. No formal exercise and physical
activity was scheduled and all subjects were restricted to
activities of daily living. All subjects had nebulised
bronchodilators prior to each physiotherapy treatment and
were receiving an antibiotic regimen of Tobramycin and
Ceftazidime titrated to weight. 
Management of acute respiratory infection includes
intravenous administration of antimicrobial drugs,
intensive physiotherapy and nutritional support. With such
regimens it has been demonstrated that pulmonary function
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Figure 1. Carry-over effect for FEV1/FVC for the therapist-assisted regimen. Shaded bars
indicate independent regimen, unshaded bars indicate therapist-assisted regimen.
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parameters, particularly those indicative of airway
obstruction (FEV
1
, FVC) distribution (RV, TLC), and
intrathoracic gas volume significantly improve following
10 to 14 days of treatment, though significant measurable
improvements have not been reported to occur before four
to seven days of treatment (Gozal et al 1993, Redding et al
1982, Regelmann et al 1990, Rosenberg and Schramm
1993). Based on these previous studies, and given the
events of the intervening 24 hours between the two test
sessions, particularly combined with the type of
physiotherapy treatment undertaken by subjects during this
time (no manual techniques, ACBT or gravity-assisted
positioning) it seems unlikely that the carry-over effect
noted with the pulmonary function tests could be ascribed
to the medical management or random occurrences in the
AB group subjects. 
While statistically significant, the clinical relevance of
these improvements in pulmonary function following
therapist-assisted treatment is unclear. These rapid
improvements suggest that the inclusion of manual
techniques has an effect on relieving airway obstruction,
possibly by facilitating mucociliary clearance. It may be
that the therapist-assisted treatment “kick-starts” airway
clearance mechanisms leading to prolonged but effective
improvements in regional or widespread airway secretion
movement. The longer term results of such improvements
remains speculative, however augmented secretion
clearance may well reduce the proteolytic burden of the
lung, resulting in slower progression of pulmonary
impairment over time (Reisman et al 1988).
Subjects with moderate pulmonary impairment (n = 3)
were observed to have higher oxygen consumption during
physiotherapy treatment when compared with subjects with
mild pulmonary impairment, but the small sample size
prohibited statistical analysis. Other authors have reported
that subjects with more severe pulmonary impairment had
greater energy requirements at rest (Bronstein et al 1995,
Fried et al 1991, Pencharz 1992) and hence may respond
differently to physiotherapy treatment which includes
manual techniques. For example, percussion combined
with thoracic expansion exercises has been reported to
result in significant increases in both inspiratory volume
and VO
2
in normal subjects (Dallimore et al 1998), raising
the concern that, in the absence of adequate time allowed
for relaxation (breathing control), deconditioned patients
with severe respiratory impairment may be unable to meet
the increased demand for oxygen. Elsewhere, anecdotal
reports of physiotherapy-related relaxation and reduced
work of breathing have often been attributed to the massage
effect of percussion rather than simply the secretion
facilitation. Furthermore, while the ACBT as investigated
in this study was consistently carried out using the same
frequency of repetitions of each of its component
techniques, in clinical practice this regimen is tailored to
suit the individual patient. At present it is unclear which of
the techniques (such as the ACBT) included in
conventional management practices are responsible for
such findings. 
Published comparisons of therapist-assisted versus
independent regimens have shown no clear differences in
outcome measures in subjects with cystic fibrosis admitted
to hospital for a respiratory exacerbation. While some
studies have reported small but significant improvements
in pulmonary function with independent physiotherapy
management (Bain et al 1988, Pryor et al 1979, Pryor et al
1981), the majority can demonstrate no significant
differences in pulmonary function parameters between
treatment techniques (Arens et al 1994, Bauer et al 1994,
Cerny 1989, Hofmeyr et al 1986, Murphy et al 1983,
Reidler et al 1996, Webber et al 1985). It is important to
note that a number of these studies (Murphy et al 1983,
Reidler et al 1996, Webber et al 1985) lacked sufficient
sample sizes to allow confident discrimination between
treatments, and increased pulmonary function variability
during recovery from exacerbations may have further
reduced the likelihood of revealing significant
improvements. 
The volume of expectorated sputum was not recorded
during this study and few subjects expectorated any sputum
at all throughout the testing procedure. Few, if any, studies
can demonstrate a relationship between expectorated
sputum volume and changes in pulmonary function.
Oberwalder et al (1991) investigated the physiotherapy
management of cystic fibrosis patients admitted to hospital
for an acute respiratory exacerbation and noted that
pulmonary function increased significantly following
physiotherapy treatments towards the end of the admission,
even though the volume of sputum expectorated was
progressively smaller. Such findings suggest that the
volume of sputum expectorated does not primarily explain
or correlate with improvements in pulmonary function.
While easily measured, sputum volume is neither a reliable
nor valid measure of chest physiotherapy as it is unlikely to
reflect secretion movement within the bronchial tree in the
absence of expectorate (Hasani et al 1994).
Previous studies have reported significant reductions in
resting energy expenditure when admission results are
compared with the day of discharge (Naon et al 1993,
Steinkamp et al 1993). In this study, five of 15 subjects had
reduced oxygen consumption at discharge compared with
admission (mean decrease 8.5%), nine subjects
demonstrated an increase (mean increase 13.4%) and one
subject did not have oxygen consumption measured at
discharge. The increases found upon discharge in this study
were unexpected and, in the absence of any other signs of
clinical deterioration, we speculate that these findings are
primarily the result of retesting the subjects immediately
prior to leaving the hospital. 
Conclusion
Energy expenditure was significantly greater during
physiotherapy treatment than at rest in this group of 15
subjects with cystic fibrosis admitted to hospital for
management of an acute respiratory exacerbation. The
modest increases in energy expenditure during
physiotherapy treatment may be due to the substantial
increase in the frequency of coughing, altered breathing
patterns and changes in respiratory muscle work. No
evidence of fatigue, oxygen desaturation or worsening
airflow obstruction was found during the initial two days of
this admission, nor during or following physiotherapy
treatment. In these subjects with mild and moderate
pulmonary impairment, neither the therapist-assisted nor
independent forms of the ACBT were found to be superior
in conserving energy required during treatment. When the
therapist-assisted ACBT was conducted on Day 1,
improvements were observed for a number of pulmonary
function parameters on the second day of testing. Although
various forms of chest physiotherapy are widely used in
ongoing management for cystic fibrosis, a clear
understanding of the mechanisms by which individual
techniques effect change is lacking. Future directions for
studies into energy expenditure and physiotherapy may
include the effect of other airways clearance techniques
(positive expiratory pressure mask, autogenic drainage),
specific positioning regimens, the influence of excessive
airway secretions, severity of pulmonary impairment and
the exploration of carry-over effects. 
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